Several elements of the Inflation Reduction Act (IRA) align with CMS’ goals of promoting equity through health policy, explained A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.
Several elements of the Inflation Reduction Act (IRA) align with CMS’ goals of promoting equity through health policy, explained A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.
Transcript
How will the elements of the IRA mesh with CMS’ efforts to overhaul payment models with an eye toward ensuring health equity?
Having worked in the area of equity enhancement and disparity reduction for 30 years, I'm extremely pleased to see the attention that this administration and this law in particular pays to enhancing equity. Specifically around the area of access and affordability, we've shown quite clearly that if you make people pay more for something, they'll buy less of it. And there's no surprise that the burden of out-of-pocket costs falls disproportionately on populations of color, those with multiple chronic conditions, and those who are financially insecure. So any policies such as an out-of-pocket cap for Medicare Part D, a decrease in out-of-pocket costs for D-rated vaccines, or broader issues that are included in this bill regarding access and affordability will hopefully lead to disproportionate benefit of these same populations of color and financial insecurity to benefit that. So I'm cautiously optimistic that many of these policies will make a small step forward regarding equity enhancement, and we're hopeful that these will mesh nicely with other CMS and CMMI initiatives to put equity enhancement first.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More